December 8, 2018, 11:49 pm

Here's Why Madrigal Pharmaceuticals Fell 39.4% in November


 08-12-2018 11:49 PM

What happened Shares of Madrigal 160 Pharmaceuticals NASDAQ MDGL 160 a clinical stage 160 biotechnology company fell 39 4 in November according to data from S amp P Global Market Intelligence Madrigal presented impressive clinical trial results for its...

Posted in:
Nasdaq Financial News
Nasdaq Financial News

This article was posted online by Nasdaq Financial News. NewsChamber collects excepts of news articles from this news source and add these in the 'Business News'-category.

'Nasdaq Financial News' is part of the category: